Blueberries Medical Corp. (BBM.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.22 Million CAD | 9.93% |
| 2022 | -811.47 Thousand CAD | -28.98% |
| 2021 | -4.04 Million CAD | 69.75% |
| 2020 | -4.1 Million CAD | 66.83% |
| 2019 | -10.49 Million CAD | -557.88% |
| 2018 | -1.59 Million CAD | -2799.65% |
| 2017 | -15.47 Thousand CAD | 86.6% |
| 2016 | -411.5 Thousand CAD | -212.62% |
| 2015 | -131.63 Thousand CAD | -44.95% |
| 2014 | -90.81 Thousand CAD | -128.43% |
| 2013 | -39.75 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -227.55 Thousand CAD | 34.61% |
| 2024 Q2 | -221.68 Thousand CAD | -31.35% |
| 2023 Q3 | -281.25 Thousand CAD | 11.24% |
| 2023 FY | - CAD | 9.93% |
| 2023 Q4 | -362.24 Thousand CAD | -28.79% |
| 2023 Q1 | -309.7 Thousand CAD | -9.17% |
| 2023 Q2 | -316.86 Thousand CAD | -2.31% |
| 2022 FY | - CAD | -28.98% |
| 2022 Q4 | -283.69 Thousand CAD | 18.62% |
| 2022 Q3 | -348.58 Thousand CAD | 11.3% |
| 2022 Q2 | -392.99 Thousand CAD | 16.48% |
| 2022 Q1 | -470.55 Thousand CAD | 25.55% |
| 2021 Q1 | -275.54 Thousand CAD | 58.74% |
| 2021 FY | - CAD | 69.75% |
| 2021 Q2 | -71.03 Thousand CAD | 74.22% |
| 2021 Q3 | -77.16 Thousand CAD | -8.63% |
| 2021 Q4 | -632.06 Thousand CAD | -719.09% |
| 2020 Q3 | -770.98 Thousand CAD | -8.26% |
| 2020 FY | - CAD | 66.83% |
| 2020 Q4 | -667.84 Thousand CAD | 13.38% |
| 2020 Q1 | -1.19 Million CAD | 11.48% |
| 2020 Q2 | -712.17 Thousand CAD | 40.63% |
| 2019 Q1 | -5.08 Million CAD | -15578.79% |
| 2019 FY | - CAD | -557.88% |
| 2019 Q4 | -1.35 Million CAD | 37.8% |
| 2019 Q3 | -2.17 Million CAD | -33.82% |
| 2019 Q2 | -1.62 Million CAD | 67.97% |
| 2018 Q1 | -7692.00 CAD | 71.2% |
| 2018 FY | - CAD | -2799.65% |
| 2018 Q4 | -32.41 Thousand CAD | -34.71% |
| 2018 Q3 | -24.06 Thousand CAD | 61.35% |
| 2018 Q2 | -62.26 Thousand CAD | -709.52% |
| 2017 Q2 | -14.12 Thousand CAD | 95.58% |
| 2017 Q1 | -319.15 Thousand CAD | -707.11% |
| 2017 FY | - CAD | 86.6% |
| 2017 Q4 | -26.71 Thousand CAD | -302.84% |
| 2017 Q3 | -6631.00 CAD | 53.04% |
| 2016 Q3 | -367.51 Thousand CAD | -1395.83% |
| 2016 Q2 | -24.56 Thousand CAD | 14.31% |
| 2016 Q1 | -28.67 Thousand CAD | 13.08% |
| 2016 FY | - CAD | -212.62% |
| 2016 Q4 | -39.54 Thousand CAD | 89.24% |
| 2015 Q1 | -25.08 Thousand CAD | -7.57% |
| 2015 FY | - CAD | -44.95% |
| 2015 Q3 | -44.59 Thousand CAD | -75.78% |
| 2015 Q4 | -32.98 Thousand CAD | 26.03% |
| 2015 Q2 | -25.37 Thousand CAD | -1.13% |
| 2014 Q4 | -23.32 Thousand CAD | 11.89% |
| 2014 Q3 | -26.46 Thousand CAD | -66.11% |
| 2014 FY | - CAD | -128.43% |
| 2014 Q2 | -15.93 Thousand CAD | 81.74% |
| 2014 Q1 | -87.25 Thousand CAD | -897.74% |
| 2013 Q4 | -8745.00 CAD | -524.64% |
| 2013 Q2 | -109.78 Thousand CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q3 | -1400.00 CAD | 98.72% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.07 Million CAD | 79.884% |
| Ayurcann Holdings Corp. | -2.01 Million CAD | 39.229% |
| The BC Bud Corporation | -1.19 Million CAD | -2.155% |
| BioNxt Solutions Inc. | -6.48 Million CAD | 81.159% |
| CordovaCann Corp. | -1.6 Million CAD | 23.763% |
| Christina Lake Cannabis Corp. | -2.62 Million CAD | 53.428% |
| Captor Capital Corp. | 2.42 Million CAD | 150.463% |
| City View Green Holdings Inc. | -2.01 Million CAD | 39.349% |
| 1CM Inc. | 1.31 Million CAD | 193.016% |
| Global Hemp Group Inc. | -24.79 Thousand CAD | -4827.96% |
| Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | 44.675% |
| IM Cannabis Corp. | -2.79 Million CAD | 56.208% |
| Lobe Sciences Ltd. | -4.4 Million CAD | 72.247% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | -211.509% |
| Mountain Valley MD Holdings Inc. | -3.19 Million CAD | 61.735% |
| Nextleaf Solutions Ltd. | 1.14 Million CAD | 207.024% |
| Ovation Science Inc. | -778.83 Thousand CAD | -56.875% |
| Pharmadrug Inc. | -1.33 Million CAD | 8.481% |
| Captiva Verde Wellness Corp. | -6.05 Million CAD | 79.825% |
| RAMM Pharma Corp. | -6.3 Million CAD | 80.613% |
| RIV Capital Inc. | -20.28 Million CAD | 93.976% |
| Revive Therapeutics Ltd. | -5.59 Million CAD | 78.163% |
| Red White & Bloom Brands Inc. | -77.59 Million CAD | 98.425% |
| SLANG Worldwide Inc. | -2.95 Million CAD | 58.593% |
| 1933 Industries Inc. | -10.03 Million CAD | 87.822% |
| Red Light Holland Corp. | -5.25 Million CAD | 76.754% |
| Top Strike Resources Corp. | -767.99 Thousand CAD | -59.089% |
| Xebra Brands Ltd. | -1.49 Million CAD | 18.275% |
| Adastra Holdings Ltd. | -1.41 Million CAD | 13.426% |